IL33 and neoplasm: Results showed that IL-33 immunoreactivity (IR) is observed in diverse cells, including adenoma/CRC cells, CD3 positive lymphocytes, SMA-alpha positive myofibroblasts and CD34 positive endothelial cells of tumor-associated microvessels (19).